Cargando…
Bullous Pemphygoid and Novel Therapeutic Approaches
Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately. Although it is a rare disease, bullous pemphigoid is the most common among the autoimmune bullous skin diseases. Systemic corticosteroids...
Autores principales: | D’Agostino, Giovanni Marco, Rizzetto, Giulio, Marani, Andrea, Marasca, Samuele, Candelora, Matteo, Gambini, Daisy, Gioacchini, Helena, De Simoni, Edoardo, Maurizi, Andrea, Campanati, Anna, Offidani, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687138/ https://www.ncbi.nlm.nih.gov/pubmed/36359364 http://dx.doi.org/10.3390/biomedicines10112844 |
Ejemplares similares
-
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
por: Rizzetto, Giulio, et al.
Publicado: (2022) -
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
por: Diotallevi, Federico, et al.
Publicado: (2023) -
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022) -
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
por: Simonetti, Oriana, et al.
Publicado: (2022) -
Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues
por: Molinelli, Elisa, et al.
Publicado: (2023)